Mayne Pharma | MYX - Assets


Mayne Pharma reported AUD1.14B in Assets for its fiscal semester ending in June of 2024.





Assets Change Date
Ansell USD 3.33B 3.2M Dec/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Cochlear AUD 2.79B 31.3M Dec/2025
CSL USD 37.9B 1.5B Dec/2025
Healius AUD 3.07B 84.2M Dec/2024
Integral Diagnostics AUD 744.28M 1.52M Jun/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Nanosonics AUD 279.25M 6.77M Dec/2025
Polynovo AUD 123.37M 4.04M Dec/2025
Ramsay Health Care AUD 21.7B 777.8M Dec/2025
ResMed USD 8.5B 195.02M Dec/2025
Sigma Healthcare AUD 8.29B 6.91B Dec/2025
Sonic Healthcare AUD 15.38B 550.57M Dec/2024
Telix Pharmaceuticals AUD 1.16B 25.97M Dec/2025